Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster

Cardiovascular Research

Volumn 69, Issue 4, 2006, Pages 888-898

  Kyoi, Shiori ^a   Otani, Hajime ^a   Matsuhisa, Seiji ^a   Akita, Yuzo ^a   Tatsumi, Kimiko ^a   Enoki, Chiharu ^a   Fujiwara, Hiroyoshi ^a   Imamura, Hiroji ^a   Kamihata, Hiroshi ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiomyopathy; Heart failure; JNK; p38 MAP kinase

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SYNAPTOPHYSIN;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; HAMSTER; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE FIBROSIS; HEART WEIGHT; MALE; MUSCLE CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTHRACENES; APOPTOSIS; CARDIOMYOPATHY, DILATED; CRICETINAE; FIBROSIS; IMIDAZOLES; IMMUNOBLOTTING; IN SITU NICK-END LABELING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICROSCOPY, FLUORESCENCE; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRAZOLES; PYRIDINES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 32444446597     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.11.015     Document Type: Article

References (29)

1. M.C. Michel, Y. Li, and G. Heusch Mitogen-activated protein kinases in the heart Naunyn Schmiedebergs Arch Pharmacol 363 2001 245 266
2. P. Liao, D. Georgakopoulos, A. Kovacs, M. Zheng, D. Lerner, and H. Pu The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy Proc Natl Acad Sci U S A 98 2001 12283 12288
3. K. Nishida, O. Yamaguchi, S. Hirotani, S. Hikoso, Y. Higuchi, and T. Watanabe p38α mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload Mol Cell Biol 24 2004 10611 10620
4. T.M. Behr, S.S. Nerurkar, A.H. Nelson, R.W. Coatney, T.N. Woods, and A. Sulpizio Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction Circulation 104 2001 1292 1298
5. F. See, W. Thomas, K. Way, A. Tzanidis, A. Kompa, and D. Lewis p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat J Am Coll Cardiol 44 2004 1679 1689
6. B.G. Petrich, B.C. Eloff, D.L. Lerner, A. Kovacs, J.E. Saffitz, and D.S. Rosenbaum Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects J Biol Chem 279 2004 15330 15338
7. J. Sadoshima, O. Montagne, Q. Wang, G. Wang, J. Warden, and J. Liu The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy J Clin Invest 110 2002 271 279
8. V. Nigro, Y. Okazaki, A. Belsito, G. Piluso, Y. Matsuda, and L. Politano Identification of the Syrian hamster cardiomyopathy gene Hum Mol Genet 6 1997 601 607
9. R.M. Fryer, H.H. Patel, A.K. Hsu, and G.J. Gross Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium Am J Physiol Heart Circ Physiol 281 2001 H1184 H1192
10. A. Clerk, and P.H. Sugden The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs) FEBS Lett 426 1998 93 96
11. S. Takahashi, Y. Keto, T. Fujita, T. Uchiyama, and A. Yamamoto FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils J Pharmacol Exp Ther 296 2001 48 56
12. B.L. Bennett, D.T. Sasaki, B.W. Murray, E.C. O'Leary, S.T. Sakata, and W. Xu SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase Proc Natl Acad Sci U S A 98 2001 13681 13686
13. W. Nadruz Jr., C.B. Kobarg, J. Kobarg, and K.G. Franchini c-Jun is regulated by combination of enhanced expression and phosphorylation in acute-overloaded rat heart Am J Physiol Heart Circ Physiol 286 2004 H760 H767
14. K. Lu, H. Otani, T. Yamamura, Y. Nakao, R. Hattori, and H. Ninomiya Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia J Thorac Cardiovasc Surg 121 2001 137 148
15. P. Widlak, P. Li, X. Wang, and W.T. Garrard Cleavage preferences of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease) on naked DNA and chromatin substrates J Biol Chem 275 2000 8226 8232
16. T. Yamamura, H. Otani, Y. Nakao, R. Hattori, M. Osako, and H. Imamura IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart Am J Physiol Heart Circ Physiol 280 2001 H1191 H1200
17. G. Jasmin, and L. Proschek Hereditary polymyopathy and cardiomyopathy in the Syrian hamster: I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line Muscle Nerve 5 1982 20 25
18. D. Wencker, M. Chandra, K. Nguyen, W. Miao, S. Garantziotis, and S.M. Factor A mechanistic role for cardiac myocyte apoptosis in heart failure J Clin Invest 111 2003 1497 1504
19. C.P. Baines, and J.D. Molkentin STRESS signaling pathways that modulate cardiac myocyte apoptosis J Mol Cell Cardiol 38 2005 47 62
20. K. Otsu, N. Yamashita, K. Nishida, S. Hirotani, O. Yamaguchi, and T. Watanabe Disruption of a single copy of the p38alpha MAP kinase gene leads to cardioprotection against ischemia-reperfusion Biochem Biophys Res Commun 302 2003 56 60
21. A.T. Saurin, J.L. Martin, R.J. Heads, C. Foley, J.W. Mockridge, and M.J. Wright The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes FASEB J 14 2000 2237 2246
22. B.J. Petrof Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex Am J Phys Med Rehabil 81 2002 S162 S174
23. Y. Wang, S. Huang, V.P. Sah, J. Ross Jr., J.H. Brown, and J. Han Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family J Biol Chem 273 1998 2161 2168
24. C. Pantos, V. Malliopoulou, I. Mourouzis, P. Moraitis, S. Tzeis, and Thempeyioti Involvement of p38 MAPK and JNK in heat stress-induced cardioprotection Basic Res Cardiol 98 2003 158 164
25. M. Sato, G.A. Cordis, N. Maulik, and D.K. Das SAPKs regulation of ischemic preconditioning Am J Physiol Heart Circ Physiol 279 2000 H901 H907
26. D. Zechner, D.J. Thuerauf, D.S. Hanford, P.M. McDonough, and C.C. Glembotski A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression J Cell Biol 139 1997 115 127
27. S. Zhang, C. Weinheimer, M. Courtois, A. Kovacs, C.E. Zhang, and A.M. Cheng The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis J Clin Invest 111 2003 833 841
28. S. Tsubata, K.R. Bowles, M. Vatta, C. Zintz, J. Titus, and L. Muhonen Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy J Clin Invest 106 2000 655 662
29. C. Badorff, G.H. Lee, B.J. Lamphear, M.E. Martone, K.P. Campbell, and R.E. Rhoads Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy Nat Med 5 1999 320 326